Canertinib
Product Specifications
CAS Number
267243-28-7
Target
EGFR, Virus Protease
Related Pathways
Microbiology/Virology, JAK/STAT signaling, Tyrosine Kinase/Adaptors, Angiogenesis
Purity
>99.99%
Bioactivity
Canertinib (CI-1033) is a pan-erbB tyrosine kinase inhibitor which work against esophageal squamous cell carcinoma in vitro and in vivo. Canertinib treatment significantly affects tumour metabolism, proliferation and hypoxia as determined by PET.
Smiles
Fc1ccc(Nc2ncnc3cc(OCCCN4CCOCC4)c(NC(=O)C=C)cc23)cc1Cl
Molecular Formula
C24H25ClFN5O3
Molecular Weight
485.94
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![6,7-Dihydro-5H-pyrrolo[1,2-a]imidazole-6-carboxylic acid hydrochloride](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
QDD31016-01 250 mg
6,7-Dihydro-5H-pyrrolo[1,2-a]imidazole-6-carboxylic acid hydrochloride
Sign In for Pricing
View Details QDD31016-02 2.5 g
6,7-Dihydro-5H-pyrrolo[1,2-a]imidazole-6-carboxylic acid hydrochloride
Sign In for Pricing
View Details H00055588-P01-25ug 25 µg
Recombinant Human MED29 Protein - (Dry Ice)
Sign In for Pricing
View Details 